Inventor · disambiguated record
Dragan Grabulovski
Also filed as: GRABULOVSKI DRAGAN
14 granted patents·10 pending applications·45 citations·filing 2007–2024
90Inventor score
Files withCOVAGEN AG10ARARIS BIOTECH AG6EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH4BRACK SIMON1EIDGENOESS TECH HOCHSCHULE1
Top patents by PatentIndex Score
24 records- 0194US9689879B2Specific and high affinity binding proteins comprising modified SH3 domains of Fyn kinaseEIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH·Filed 2016·Granted Jun 27, 2017·7 cites·7 claims
- 0292US9989536B2Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinaseEIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH·Filed 2017·Granted Jun 5, 2018·5 cites·7 claims
- 0390US10996226B2Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinaseEIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH·Filed 2018·Granted May 4, 2021·4 cites·4 claims
- 0486US9513296B2Specific and high affinity binding proteins comprising modified SH3 domains of Fyn kinaseEIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH·Filed 2014·Granted Dec 6, 2016·6 cites·4 claims
- 0582US10323095B2Antibody-fynomer conjugatesMITSUBISHI TANABE PHARMA CORP·Filed 2015·Granted Jun 18, 2019·7 cites·20 claims
- 0680US10364419B2Human serum albumin binding compounds and fusion proteins thereofCOVAGEN AG·Filed 2017·Granted Jul 30, 2019·3 cites·10 claims
- 0779US9790475B2Human serum albumin binding compounds and fusion proteins thereofCOVAGEN AG·Filed 2013·Granted Oct 17, 2017·4 cites·8 claims
- 0878US9593314B2Binding molecules with antitumoral activityCOVAGEN AG·Filed 2013·Granted Mar 14, 2017·5 cites·10 claims
- 0966US12076412B2Antibody-drug conjugates through specific linker oligopeptidesARARIS BIOTECH AG·Filed 2023·Granted Sep 3, 2024·0 cites·26 claims
- 1066US9085760B2Chymase binding compounds and medical uses thereofBRACK SIMON·Filed 2012·Granted Jul 21, 2015·3 cites·8 claims
- 1166US2025049943A1Means and methods for producing antibody-linker conjugatesARARIS BIOTECH AG·Filed 2024·Application pending·0 cites
- 1265US2024366782A1Means and methods for producing antibody-linker conjugatesARARIS BIOTECH AG·Filed 2024·Application pending·0 cites
- 1358US9315557B2IL-17A binding molecules and medical uses thereofCOVAGEN AG·Filed 2013·Granted Apr 19, 2016·1 cites·18 claims
- 1458US2025082774A1Peptide linkers comprising two or more payloadsARARIS BIOTECH AG·Filed 2024·Application pending·0 cites
- 1558US2024398972A1Methods for producing antibody-linker conjugatesARARIS BIOTECH AG·Filed 2024·Application pending·0 cites
- 1653US11351267B2FGFR3 binding moleculesCOVAGEN AG·Filed 2020·Granted Jun 7, 2022·0 cites·12 claims
- 1753US2023372525A1Transglutaminase conjugation method with amino acid-based linkersARARIS BIOTECH AG·Filed 2023·Application pending·0 cites
- 1851US10722589B2FGFR3 binding moleculesCOVAGEN AG·Filed 2018·Granted Jul 28, 2020·0 cites·12 claims
- 1947US2010119446A1Specific and high affinity binding proteins comprising modified sh3 domains of fyn kinaseEIDGENOESS TECH HOCHSCHULE·Filed 2007·Application pending·0 cites
- 2042US2017281768A1Novel nucleic acid molecules with antitumoral activityCOVAGEN AG·Filed 2017·Application pending·0 cites
- 2140US2019100587A1IgG1 Fc MUTANTS WITH ABLATED EFFECTOR FUNCTIONSCOVAGEN AG·Filed 2018·Application pending·0 cites
- 2239US9376477B2IL-17 binding compounds and medical uses thereofGRABULOVSKI DRAGAN·Filed 2010·Granted Jun 28, 2016·0 cites·15 claims
- 2339US2016368957A1IL-17 Binding Compounds and Medical Uses ThereofCOVAGEN AG·Filed 2016·Application pending·0 cites
- 2437US2019153096A1Cd3/cd33 bispecific binding moleculesCOVAGEN AG·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dragan Grabulovski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →